全文获取类型
收费全文 | 2556篇 |
免费 | 229篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 106篇 |
妇产科学 | 26篇 |
基础医学 | 351篇 |
口腔科学 | 56篇 |
临床医学 | 363篇 |
内科学 | 613篇 |
皮肤病学 | 19篇 |
神经病学 | 200篇 |
特种医学 | 297篇 |
外国民族医学 | 1篇 |
外科学 | 223篇 |
综合类 | 48篇 |
一般理论 | 2篇 |
预防医学 | 211篇 |
眼科学 | 48篇 |
药学 | 144篇 |
中国医学 | 5篇 |
肿瘤学 | 74篇 |
出版年
2021年 | 24篇 |
2020年 | 21篇 |
2019年 | 30篇 |
2018年 | 39篇 |
2017年 | 27篇 |
2016年 | 42篇 |
2015年 | 39篇 |
2014年 | 65篇 |
2013年 | 60篇 |
2012年 | 89篇 |
2011年 | 77篇 |
2010年 | 65篇 |
2009年 | 92篇 |
2008年 | 85篇 |
2007年 | 88篇 |
2006年 | 78篇 |
2005年 | 82篇 |
2004年 | 92篇 |
2003年 | 85篇 |
2002年 | 79篇 |
2001年 | 66篇 |
2000年 | 63篇 |
1999年 | 61篇 |
1998年 | 62篇 |
1997年 | 62篇 |
1996年 | 78篇 |
1995年 | 58篇 |
1994年 | 48篇 |
1993年 | 56篇 |
1992年 | 66篇 |
1991年 | 51篇 |
1990年 | 59篇 |
1989年 | 68篇 |
1988年 | 72篇 |
1987年 | 70篇 |
1986年 | 76篇 |
1985年 | 42篇 |
1984年 | 30篇 |
1983年 | 31篇 |
1982年 | 35篇 |
1981年 | 25篇 |
1980年 | 19篇 |
1979年 | 23篇 |
1977年 | 29篇 |
1976年 | 28篇 |
1975年 | 30篇 |
1974年 | 21篇 |
1972年 | 21篇 |
1971年 | 23篇 |
1969年 | 16篇 |
排序方式: 共有2792条查询结果,搜索用时 0 毫秒
991.
992.
Hill ME; MacLennan KA; Cunningham DC; Vaughan Hudson B; Burke M; Clarke P; Di Stefano F; Anderson L; Vaughan Hudson G; Mason D; Selby P; Linch DC 《Blood》1996,88(3):1046-1051
The Bcl-2 protein is capable of preventing apoptosis, and in vitro evidence suggests a role in drug resistance. It is expressed and the gene is rearranged in a proportion of cases of large-cell non-Hodgkin's lymphoma (NHL), but the clinical significance of these findings is controversial. The purpose of this study was to determine the influence of both Bcl-2 expression and major breakpoint region (MBR) bcl-2 rearrangement in a large cohort of prospectively accrued patients with intermediate-grade B-cell NHL treated in a standardized manner. All patients with Working Formulation F, G, or H NHL treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy in British National Lymphoma investigation studies between July 1974 and April 1992 were considered for this study if the appropriate paraffin blocks were available. Paraffin sections from the diagnostic specimen were analyzed for evidence of MBR rearrangement using a polymerase chain reaction-based method, and for Bcl-2 expression using immunohistochemistry. Failure to achieve complete remission (CR), relapse, death from NHL, and deaths from all causes were used as end points to measure CR rate, actuarial relapse rate, actuarial survival from NHL, and actuarial overall survival. One hundred sixty-one suitable patients were identified and tested for the bcl-2 MBR translocation, with 27 (17%) found to be positive; 153 of these patients were tested with immunocytochemistry, and 84 (55%) showed evidence of Bcl-2 expression. For patients who achieved CR from the initial treatment, the relapse rate was significantly higher in those with Bcl-2 expression than in those without. In addition, multivariate analysis identified Bcl-2 expression as the only factor significantly related to relapse rate in the subjects measured. The cause-specific survival for NHL in the series as a whole was significantly lower in patients with Bcl-2 expression than in those without. MBR status had no significant influence on any of the outcome measures, but the number of MBR-positive patients was relatively small, and larger studies are required. In conclusion, in Working Formulation F, G, and H NHL of B-cell type, expression of Bcl-2 protein predicted independently for relapse. 相似文献
993.
994.
995.
996.
DDAVP in type IIa von Willebrand's disease 总被引:1,自引:0,他引:1
Gralnick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y 《Blood》1986,67(2):465-468
1-D-Amino(8-D-arginine)-vasopressin (DDAVP) infusion in three patients with type IIa von Willebrand's disease (vWD) resulted in a normalization of the factor VIII coagulant, factor VIII-related antigen, and von Willebrand factor (vWF) (ristocetin cofactor) activities and the bleeding time. The normalization of these hemostatic parameters persisted for four hours. Over the same time period there was a marked increase in the quantity of the vWF multimers when blood was collected in the presence of protease inhibitors. The vWF multimers present were even larger than the normal. When blood was collected in the absence of protease inhibitors, a smaller increase in the plasma vWF multimers was observed and fewer of the intermediate and larger vWF multimers were seen; multimers larger than those present in normal plasma were not visualized. The platelet vWF multimers and activities did not change with or without inhibitors. These studies suggest that there is a subgroup of patients with type IIa vWD who respond to DDAVP with complete normalization of their hemostatic abnormalities and whose vWF is sensitive to proteolysis. 相似文献
997.
998.
999.
Daniel A. Bayhi MD JD RPh Cynthia D. A. Sherwood MD Carol E. Campbell MD 《Journal of clinical anesthesia》1992,4(6):487-488
Uterine inversion following vaginal delivery or during Cesarean section is rare. Cardiovascular instability resulting from blood loss is possible. This article describes the use of intravenous nitroglycerin as an alternative to the induction of general anesthesia and administration of volatile anesthetics to provide uterine relaxation. 相似文献
1000.
RK Cady D Gutterman JA Saiers ME Beach 《Cephalalgia : an international journal of headache》1997,17(5):588-590
In a long-term efficacy and satiety study, 424 patients were treated with sumatriptan (6 mg sc) for 1,904 migraine attacks. The patients were diagnosed with migraine based on IHS criteria but individual migraine attacks treated in the study were physician diagnosed; not necessarily required to meet IHS criteria. A re-analysis of the treatment response to open label sumatriptan (6 mg sc) indicated that 43 patients had treated at least one migraine that fulfilled IHS criteria for tension-type headache. Analysis of this population revealed they treated 232 headaches. Of these headaches, 114 were classified per IHS criteria as migraine; 76 as tension-type; and 42 as. non-IHS migraine (not classifiable as IHS migraine or IHS tension-type headache). Of the 114 migraines a positive response to sumatriptan occurred in 109 (96%) cases; of the 76 tension-types, 73 responded to sumatriptan (97%); of the 42 non-IHS migraine, 40 (95%) responded to sumatriptan. An equivalent response to sumatriptan among three diagnostic groups of headache supports the concept of a common biologic mechanism involving 5HT1 receptors that spans a range of clinical presentations. 相似文献